These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19335130)

  • 1. Pathophysiology and genetic factors in moyamoya disease.
    Achrol AS; Guzman R; Lee M; Steinberg GK
    Neurosurg Focus; 2009 Apr; 26(4):E4. PubMed ID: 19335130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moyamoya disease: a review of histopathology, biochemistry, and genetics.
    Weinberg DG; Arnaout OM; Rahme RJ; Aoun SG; Batjer HH; Bendok BR
    Neurosurg Focus; 2011 Jun; 30(6):E20. PubMed ID: 21631222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis and radiobiology of brain arteriovenous malformations: implications for risk stratification in natural history and posttreatment course.
    Achrol AS; Guzman R; Varga M; Adler JR; Steinberg GK; Chang SD
    Neurosurg Focus; 2009 May; 26(5):E9. PubMed ID: 19409010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding and treating moyamoya disease in children.
    Smith JL
    Neurosurg Focus; 2009 Apr; 26(4):E4. PubMed ID: 19335128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics of Moyamoya disease.
    Roder C; Nayak NR; Khan N; Tatagiba M; Inoue I; Krischek B
    J Hum Genet; 2010 Nov; 55(11):711-6. PubMed ID: 20739943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review of past research and current concepts on the etiology of moyamoya disease.
    Houkin K; Ito M; Sugiyama T; Shichinohe H; Nakayama N; Kazumata K; Kuroda S
    Neurol Med Chir (Tokyo); 2012; 52(5):267-77. PubMed ID: 22688062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial moyamoya disease in two Turkish siblings with same polymorphism in RNF213 gene but different clinical features.
    Bayram AK; Yilmaz E; Per H; Ito M; Uchino H; Doganay S; Houkin K; Unal E
    Childs Nerv Syst; 2016 Mar; 32(3):569-73. PubMed ID: 26277359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current knowledge on the genetic factors involved in moyamoya disease].
    Hashikata H; Liu W; Mineharu Y; Inoue K; Takenaka K; Ikeda H; Houkin K; Kuroda S; Kikuchi K; Kimura M; Taki T; Sonobe M; Ban S; Nogaki H; Handa A; Kikuta K; Takagi Y; Nozaki K; Hashimoto N; Koizumi A
    Brain Nerve; 2008 Nov; 60(11):1261-9. PubMed ID: 19069159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of transforming growth factor-beta1 in the pathogenesis of moyamoya disease.
    Hojo M; Hoshimaru M; Miyamoto S; Taki W; Nagata I; Asahi M; Matsuura N; Ishizaki R; Kikuchi H; Hashimoto N
    J Neurosurg; 1998 Oct; 89(4):623-9. PubMed ID: 9761057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasculogenic and Angiogenic Pathways in Moyamoya Disease.
    Bedini G; Blecharz KG; Nava S; Vajkoczy P; Alessandri G; Ranieri M; Acerbi F; Ferroli P; Riva D; Esposito S; Pantaleoni C; Nardocci N; Zibordi F; Ciceri E; Parati EA; Bersano A
    Curr Med Chem; 2016; 23(4):315-45. PubMed ID: 26861126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of serum Matrix Metalloproteinase-9 in patients with moyamoya disease.
    Fujimura M; Watanabe M; Narisawa A; Shimizu H; Tominaga T
    Surg Neurol; 2009 Nov; 72(5):476-80; discussion 480. PubMed ID: 19147196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moyamoya, unilateral to bilateral in one year.
    Veselinovic N; Zidverc-Trajkovic J; Semnic R; Tomic G; Sternic N; Bjelan M
    Vasa; 2014 Jul; 43(4):284-6. PubMed ID: 25007907
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of Inflammatory Disease on the Pathophysiology of Moyamoya Disease and Quasi-moyamoya Disease.
    Mikami T; Suzuki H; Komatsu K; Mikuni N
    Neurol Med Chir (Tokyo); 2019 Oct; 59(10):361-370. PubMed ID: 31281171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The collateral circulation in pediatric moyamoya disease.
    Baltsavias G; Khan N; Valavanis A
    Childs Nerv Syst; 2015 Mar; 31(3):389-98. PubMed ID: 25378261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel susceptibility locus for moyamoya disease on chromosome 8q23.
    Sakurai K; Horiuchi Y; Ikeda H; Ikezaki K; Yoshimoto T; Fukui M; Arinami T
    J Hum Genet; 2004; 49(5):278-81. PubMed ID: 15362573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease.
    Blecharz KG; Frey D; Schenkel T; Prinz V; Bedini G; Krug SM; Czabanka M; Wagner J; Fromm M; Bersano A; Vajkoczy P
    J Cereb Blood Flow Metab; 2017 Apr; 37(4):1527-1539. PubMed ID: 27381827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya.
    Miskinyte S; Butler MG; Hervé D; Sarret C; Nicolino M; Petralia JD; Bergametti F; Arnould M; Pham VN; Gore AV; Spengos K; Gazal S; Woimant F; Steinberg GK; Weinstein BM; Tournier-Lasserve E
    Am J Hum Genet; 2011 Jun; 88(6):718-728. PubMed ID: 21596366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in moyamoya disease: pathophysiology and treatment.
    Kronenburg A; Braun KP; van der Zwan A; Klijn CJ
    Curr Neurol Neurosci Rep; 2014 Jan; 14(1):423. PubMed ID: 24310442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental animal models for the study of moyamoya disease.
    Letchuman V; Ampie L; Mastorakos P; Raper DMS; Kellogg RT; Park MS
    Neurosurg Focus; 2021 Sep; 51(3):E4. PubMed ID: 34469866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of moyamoya disease: a review.
    Baaj AA; Agazzi S; Sayed ZA; Toledo M; Spetzler RF; van Loveren H
    Neurosurg Focus; 2009 Apr; 26(4):E7. PubMed ID: 19335133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.